SlideShare a Scribd company logo
1 of 16
Download to read offline
Randomized Trial of a Clinical Decision Support System:
 Impact on the Management of Children with Fever
 without Apparent Source
  JOLT ROUKEMA, MD, PHD, EWOUT W. STEYERBERG, PHD, JOHAN VAN DER LEI, MD, PHD,
  HENRIËTTE A. MOLL, MD, PHD

  J Am Med Inform Assoc. 2008;15:107–113.




                                                     Speaker : Yen-Chih Huang
                                                     Advisor : Yu-Chuan Li
Introduction

  Fever Without apparent Source (FWS)
 - body temperature ≧ 38.0 degrees Celsius
 - no apparent source found after evaluation
  Serious Bacterial Infection (SBI)
  1 – 36 months
  Sophia Children’s Hospital ( 2003.9.1 – 2005.12.31 )

  Time spent at the ED
  Identified SBI



Page 2
OpenSDE




          http://www2.eur.nl/fgg/mi/OpenSDE/


Page 3
Two Rules

  GP-referred (general practitioner)
  Self-referred




Page 4
GP-referred




Page 5
Self-referred




Page 6
1744 Febrile children,
             1-36 months

                                                375 chronic co-morbidity

             1399 Eligible

                                                   716 not registered

         683 CDSS - Registered

                                            293 Fever with a clear source

         390 Patients with FWS

                                                  218 Low risk-score

             172 High risk-score & randomized
                ( Informed consent n = 164 )



         74 Order laboratory tests       90 Routine evaluation by physician




Page 7
Methods

  Randomization ( 1-1000 )
 - odd : intervention group (order laboratory tests)
 - even : control group


  laboratory tests
 - complete blood count (CBC)
 - C-reactive protein (CRP)




Page 8
Measurements

  ED time
 - arrival time ~ departure time
  Serious Bacterial Infection (SBI)
 - culture or radiographically




Page 9
1744 Febrile children,
Results             1-36 months

                                                       375 chronic co-morbidity

                    1399 Eligible

                                                          716 not registered

          49%   683 CDSS - Registered

                                                   293 Fever with a clear source

          57%   390 Patients with FWS

                                                         218 Low risk-score

                    172 High risk-score & randomized
                       ( Informed consent n = 164 )

                                95% (164/172)
                74 Order laboratory tests       90 Routine evaluation by physician




Page 10
Results

 Laboratory tests:
 - intervention group : 82% ( 61/74 )
 - control group : 44% ( 40/90 )




Page 11
Results




Page 12
Results




     30 patients missing time of arrival at or departure from the ED
     (16 in the intervention group, 14 in the control group)



Page 13
Results




Page 14
Conclusion

  Time constraints
  ED nurses were aware the decision rule
  FWS registration rate is relatively high
  Laboratory tests affected diagnostic testing

  The prediction rules need adjustment
  Reduce false high-risk
  Increasing the risk-score threshold




Page 15
九
                        十
                        七
                        年
                        十
                        二

          THANK YOU !   月
                        一
                        日

                        天
                        氣
                        :
                        陰


Page 16

More Related Content

Viewers also liked

以網站原型來確認需求 – 電子商務網站的購物動線規劃
以網站原型來確認需求 – 電子商務網站的購物動線規劃以網站原型來確認需求 – 電子商務網站的購物動線規劃
以網站原型來確認需求 – 電子商務網站的購物動線規劃悠識學院
 
Web 2.0 based Application/Website development for Hospitality industry
Web 2.0 based Application/Website development for Hospitality industryWeb 2.0 based Application/Website development for Hospitality industry
Web 2.0 based Application/Website development for Hospitality industrySandeep Sivaram
 
Parenting 21st Century Children
Parenting 21st Century ChildrenParenting 21st Century Children
Parenting 21st Century ChildrenGraham Whisen
 
Presentation Domian Names Eqypt (Final)
Presentation Domian Names Eqypt (Final)Presentation Domian Names Eqypt (Final)
Presentation Domian Names Eqypt (Final)guestb0dfbbf
 
BSN Central FedBid Presentation
BSN Central FedBid Presentation BSN Central FedBid Presentation
BSN Central FedBid Presentation curtiswynn
 
Redwood Cradle to cradle Innov_ex 09
Redwood Cradle to cradle Innov_ex 09 Redwood Cradle to cradle Innov_ex 09
Redwood Cradle to cradle Innov_ex 09 Mary Rose
 
淺談 Domain name 網域名稱姓名學 by Ben Lin
淺談 Domain name 網域名稱姓名學 by Ben Lin淺談 Domain name 網域名稱姓名學 by Ben Lin
淺談 Domain name 網域名稱姓名學 by Ben Lin悠識學院
 
Telefónia a VoIP barcamp
Telefónia a VoIP barcampTelefónia a VoIP barcamp
Telefónia a VoIP barcampJuraj Bednar
 
人多嘴雜乎?眾志成城乎?開放源碼軟體的使用體驗 by Bob Chao
人多嘴雜乎?眾志成城乎?開放源碼軟體的使用體驗 by Bob Chao人多嘴雜乎?眾志成城乎?開放源碼軟體的使用體驗 by Bob Chao
人多嘴雜乎?眾志成城乎?開放源碼軟體的使用體驗 by Bob Chao悠識學院
 
Trade show techology trends
Trade show techology trendsTrade show techology trends
Trade show techology trendsMichelle Bruno
 
Collaborize Overview
Collaborize OverviewCollaborize Overview
Collaborize OverviewRBolden
 
Bluesign Innovation For Extremes 06.05.2009
Bluesign Innovation For Extremes 06.05.2009Bluesign Innovation For Extremes 06.05.2009
Bluesign Innovation For Extremes 06.05.2009Mary Rose
 

Viewers also liked (20)

World Event: swine flu
World Event: swine fluWorld Event: swine flu
World Event: swine flu
 
以網站原型來確認需求 – 電子商務網站的購物動線規劃
以網站原型來確認需求 – 電子商務網站的購物動線規劃以網站原型來確認需求 – 電子商務網站的購物動線規劃
以網站原型來確認需求 – 電子商務網站的購物動線規劃
 
Mobile Web & Widgets
Mobile Web & WidgetsMobile Web & Widgets
Mobile Web & Widgets
 
Web 2.0 based Application/Website development for Hospitality industry
Web 2.0 based Application/Website development for Hospitality industryWeb 2.0 based Application/Website development for Hospitality industry
Web 2.0 based Application/Website development for Hospitality industry
 
Parenting 21st Century Children
Parenting 21st Century ChildrenParenting 21st Century Children
Parenting 21st Century Children
 
Presentation Domian Names Eqypt (Final)
Presentation Domian Names Eqypt (Final)Presentation Domian Names Eqypt (Final)
Presentation Domian Names Eqypt (Final)
 
Swim_2013_02_19_jpn
Swim_2013_02_19_jpnSwim_2013_02_19_jpn
Swim_2013_02_19_jpn
 
BSN Central FedBid Presentation
BSN Central FedBid Presentation BSN Central FedBid Presentation
BSN Central FedBid Presentation
 
Pp2
Pp2Pp2
Pp2
 
Redwood Cradle to cradle Innov_ex 09
Redwood Cradle to cradle Innov_ex 09 Redwood Cradle to cradle Innov_ex 09
Redwood Cradle to cradle Innov_ex 09
 
淺談 Domain name 網域名稱姓名學 by Ben Lin
淺談 Domain name 網域名稱姓名學 by Ben Lin淺談 Domain name 網域名稱姓名學 by Ben Lin
淺談 Domain name 網域名稱姓名學 by Ben Lin
 
Engage 2010
Engage 2010Engage 2010
Engage 2010
 
Telefónia a VoIP barcamp
Telefónia a VoIP barcampTelefónia a VoIP barcamp
Telefónia a VoIP barcamp
 
Sectors De ProducciçO
Sectors De ProducciçOSectors De ProducciçO
Sectors De ProducciçO
 
人多嘴雜乎?眾志成城乎?開放源碼軟體的使用體驗 by Bob Chao
人多嘴雜乎?眾志成城乎?開放源碼軟體的使用體驗 by Bob Chao人多嘴雜乎?眾志成城乎?開放源碼軟體的使用體驗 by Bob Chao
人多嘴雜乎?眾志成城乎?開放源碼軟體的使用體驗 by Bob Chao
 
Trade show techology trends
Trade show techology trendsTrade show techology trends
Trade show techology trends
 
Collaborize Overview
Collaborize OverviewCollaborize Overview
Collaborize Overview
 
Bluesign Innovation For Extremes 06.05.2009
Bluesign Innovation For Extremes 06.05.2009Bluesign Innovation For Extremes 06.05.2009
Bluesign Innovation For Extremes 06.05.2009
 
Why Research?
Why Research?Why Research?
Why Research?
 
Honda Cycles
Honda CyclesHonda Cycles
Honda Cycles
 

Similar to Randomized Trial of a Clinical Decision Support System

Dr. Dyneah Classen - Management and challenges of dealing with swine influenza
Dr. Dyneah Classen - Management and challenges of dealing with swine influenzaDr. Dyneah Classen - Management and challenges of dealing with swine influenza
Dr. Dyneah Classen - Management and challenges of dealing with swine influenzaJohn Blue
 
Ravi Kumar Xcyton Innovative Diagnostic
Ravi Kumar  Xcyton Innovative DiagnosticRavi Kumar  Xcyton Innovative Diagnostic
Ravi Kumar Xcyton Innovative DiagnosticEmTech
 
Sepsis biomarkers an update by Dr Puneet Jain
Sepsis biomarkers an update by Dr Puneet JainSepsis biomarkers an update by Dr Puneet Jain
Sepsis biomarkers an update by Dr Puneet JainPuneet Jain
 
Sturge weber syndrome
Sturge weber syndrome Sturge weber syndrome
Sturge weber syndrome Hemant Santosh
 
atypical neonatal infection
atypical neonatal infectionatypical neonatal infection
atypical neonatal infectionmandar haval
 
Dr. Mike Roof - Impact of Porcine Reproductive & Respiratory Syndrome (PRRS) ...
Dr. Mike Roof - Impact of Porcine Reproductive & Respiratory Syndrome (PRRS) ...Dr. Mike Roof - Impact of Porcine Reproductive & Respiratory Syndrome (PRRS) ...
Dr. Mike Roof - Impact of Porcine Reproductive & Respiratory Syndrome (PRRS) ...John Blue
 
Newborn Screening: Part III
Newborn Screening: Part IIINewborn Screening: Part III
Newborn Screening: Part IIICHC Connecticut
 
Fever Without a Focus in the Neonate.pptx
Fever Without a Focus in the Neonate.pptxFever Without a Focus in the Neonate.pptx
Fever Without a Focus in the Neonate.pptxWalaa Manaa
 
Neonatal herpes simplex infections
Neonatal herpes simplex infectionsNeonatal herpes simplex infections
Neonatal herpes simplex infectionsMahishma Konidala
 
Evaluating Pediatric Fever
Evaluating Pediatric FeverEvaluating Pediatric Fever
Evaluating Pediatric FeverSondraBaumcratz
 
Dr. Richard Kerr - Development of an Effective Pathogen Screening Program usi...
Dr. Richard Kerr - Development of an Effective Pathogen Screening Program usi...Dr. Richard Kerr - Development of an Effective Pathogen Screening Program usi...
Dr. Richard Kerr - Development of an Effective Pathogen Screening Program usi...John Blue
 
Interim Guidelines in the Management and Prevention of Ebola Virus Disease as...
Interim Guidelines in the Management and Prevention of Ebola Virus Disease as...Interim Guidelines in the Management and Prevention of Ebola Virus Disease as...
Interim Guidelines in the Management and Prevention of Ebola Virus Disease as...Arthur Dessi Roman
 
Duty Report 19 maret 2024 edit abi 4.pptx
Duty Report 19 maret 2024 edit abi 4.pptxDuty Report 19 maret 2024 edit abi 4.pptx
Duty Report 19 maret 2024 edit abi 4.pptxyuliaoksiyulanda
 

Similar to Randomized Trial of a Clinical Decision Support System (20)

Dr. Dyneah Classen - Management and challenges of dealing with swine influenza
Dr. Dyneah Classen - Management and challenges of dealing with swine influenzaDr. Dyneah Classen - Management and challenges of dealing with swine influenza
Dr. Dyneah Classen - Management and challenges of dealing with swine influenza
 
Ravi Kumar Xcyton Innovative Diagnostic
Ravi Kumar  Xcyton Innovative DiagnosticRavi Kumar  Xcyton Innovative Diagnostic
Ravi Kumar Xcyton Innovative Diagnostic
 
Sepsis biomarkers an update by Dr Puneet Jain
Sepsis biomarkers an update by Dr Puneet JainSepsis biomarkers an update by Dr Puneet Jain
Sepsis biomarkers an update by Dr Puneet Jain
 
Sturge weber syndrome
Sturge weber syndrome Sturge weber syndrome
Sturge weber syndrome
 
atypical neonatal infection
atypical neonatal infectionatypical neonatal infection
atypical neonatal infection
 
Dengue
DengueDengue
Dengue
 
16S PCR.pptx
16S PCR.pptx16S PCR.pptx
16S PCR.pptx
 
Dr. Mike Roof - Impact of Porcine Reproductive & Respiratory Syndrome (PRRS) ...
Dr. Mike Roof - Impact of Porcine Reproductive & Respiratory Syndrome (PRRS) ...Dr. Mike Roof - Impact of Porcine Reproductive & Respiratory Syndrome (PRRS) ...
Dr. Mike Roof - Impact of Porcine Reproductive & Respiratory Syndrome (PRRS) ...
 
malaria.pptx
malaria.pptxmalaria.pptx
malaria.pptx
 
Newborn Screening: Part III
Newborn Screening: Part IIINewborn Screening: Part III
Newborn Screening: Part III
 
Fever Without a Focus in the Neonate.pptx
Fever Without a Focus in the Neonate.pptxFever Without a Focus in the Neonate.pptx
Fever Without a Focus in the Neonate.pptx
 
Neonatal herpes simplex infections
Neonatal herpes simplex infectionsNeonatal herpes simplex infections
Neonatal herpes simplex infections
 
Evaluating Pediatric Fever
Evaluating Pediatric FeverEvaluating Pediatric Fever
Evaluating Pediatric Fever
 
ASTMH2014 E_Baum
ASTMH2014 E_BaumASTMH2014 E_Baum
ASTMH2014 E_Baum
 
Dr. Richard Kerr - Development of an Effective Pathogen Screening Program usi...
Dr. Richard Kerr - Development of an Effective Pathogen Screening Program usi...Dr. Richard Kerr - Development of an Effective Pathogen Screening Program usi...
Dr. Richard Kerr - Development of an Effective Pathogen Screening Program usi...
 
Pediatric fever
Pediatric feverPediatric fever
Pediatric fever
 
Post Exposure Prophylaxis
Post Exposure ProphylaxisPost Exposure Prophylaxis
Post Exposure Prophylaxis
 
Interim Guidelines in the Management and Prevention of Ebola Virus Disease as...
Interim Guidelines in the Management and Prevention of Ebola Virus Disease as...Interim Guidelines in the Management and Prevention of Ebola Virus Disease as...
Interim Guidelines in the Management and Prevention of Ebola Virus Disease as...
 
ASTHMA-AdCon.pptx
ASTHMA-AdCon.pptxASTHMA-AdCon.pptx
ASTHMA-AdCon.pptx
 
Duty Report 19 maret 2024 edit abi 4.pptx
Duty Report 19 maret 2024 edit abi 4.pptxDuty Report 19 maret 2024 edit abi 4.pptx
Duty Report 19 maret 2024 edit abi 4.pptx
 

Randomized Trial of a Clinical Decision Support System

  • 1. Randomized Trial of a Clinical Decision Support System: Impact on the Management of Children with Fever without Apparent Source JOLT ROUKEMA, MD, PHD, EWOUT W. STEYERBERG, PHD, JOHAN VAN DER LEI, MD, PHD, HENRIËTTE A. MOLL, MD, PHD J Am Med Inform Assoc. 2008;15:107–113. Speaker : Yen-Chih Huang Advisor : Yu-Chuan Li
  • 2. Introduction Fever Without apparent Source (FWS) - body temperature ≧ 38.0 degrees Celsius - no apparent source found after evaluation Serious Bacterial Infection (SBI) 1 – 36 months Sophia Children’s Hospital ( 2003.9.1 – 2005.12.31 ) Time spent at the ED Identified SBI Page 2
  • 3. OpenSDE http://www2.eur.nl/fgg/mi/OpenSDE/ Page 3
  • 4. Two Rules GP-referred (general practitioner) Self-referred Page 4
  • 7. 1744 Febrile children, 1-36 months 375 chronic co-morbidity 1399 Eligible 716 not registered 683 CDSS - Registered 293 Fever with a clear source 390 Patients with FWS 218 Low risk-score 172 High risk-score & randomized ( Informed consent n = 164 ) 74 Order laboratory tests 90 Routine evaluation by physician Page 7
  • 8. Methods Randomization ( 1-1000 ) - odd : intervention group (order laboratory tests) - even : control group laboratory tests - complete blood count (CBC) - C-reactive protein (CRP) Page 8
  • 9. Measurements ED time - arrival time ~ departure time Serious Bacterial Infection (SBI) - culture or radiographically Page 9
  • 10. 1744 Febrile children, Results 1-36 months 375 chronic co-morbidity 1399 Eligible 716 not registered 49% 683 CDSS - Registered 293 Fever with a clear source 57% 390 Patients with FWS 218 Low risk-score 172 High risk-score & randomized ( Informed consent n = 164 ) 95% (164/172) 74 Order laboratory tests 90 Routine evaluation by physician Page 10
  • 11. Results Laboratory tests: - intervention group : 82% ( 61/74 ) - control group : 44% ( 40/90 ) Page 11
  • 13. Results 30 patients missing time of arrival at or departure from the ED (16 in the intervention group, 14 in the control group) Page 13
  • 15. Conclusion Time constraints ED nurses were aware the decision rule FWS registration rate is relatively high Laboratory tests affected diagnostic testing The prediction rules need adjustment Reduce false high-risk Increasing the risk-score threshold Page 15
  • 16. 十 七 年 十 二 THANK YOU ! 月 一 日 天 氣 : 陰 Page 16